Condition

Endocrinology

ClinicalTrials.gov condition label

Clinical trials2

Recruiting0

Common interventions4

Lead sponsors shown2

Clinical trials

2 shown

Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor AgonistNCT06851858 · 2025-03-12

COMPLETED

Interest of FSL 2 in Recently Diagnosed Type 2 Diabetic PatientsNCT05676593 · 2023-05-03

TERMINATED

Common interventions

AZD6234DRUG1Freestyle Libre 2DEVICE1Placebo to matchDRUG1Therapeutic educationOTHER1

Leading sponsors

AstraZeneca1University Hospital, Montpellier1

Trial status mix

COMPLETED1

TERMINATED1

Phase mix

NA1

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.